Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00739518
Other study ID # HUM00041731
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date October 2004
Est. completion date January 14, 2020

Study information

Verified date March 2021
Source University of Michigan
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study is being done to assess new Magnetic Resonance Imaging (MRI) technologies such as new hardware or software designed to improve MRI examinations of the brain, spine head and neck regions.


Description:

This study is being done to assess new Magnetic Resonance Imaging (MRI) technologies such as new hardware or software designed to improve MRI examinations of the brain, spine, and head & neck regions. Software and hardware are constantly being improved, new machines replace old machines, software is updated and improved as are the devices used to produce better MRI images.


Recruitment information / eligibility

Status Completed
Enrollment 500
Est. completion date January 14, 2020
Est. primary completion date January 14, 2020
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - If you are a male or a non-pregnant female patient - Normal volunteer - presenting to MRI for a clinically-ordered neurological or head and neck MRI exam Exclusion Criteria: - Patients, who have electrically, magnetically or mechanically activated implants such as heart pacemaker, magnetic surgical clips, prostheses or implanted neurological stimulator. - Pregnant patients or patients who are lactating. - A patient who is claustrophobic

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
MRI
Neurological MRI with new technology evaluation. The new technology may involve software or MRI scanning sequences. This is a long term research study that focuses on new technology that is constantly being created.

Locations

Country Name City State
United States University of Michigan Health System Ann Arbor Michigan

Sponsors (3)

Lead Sponsor Collaborator
University of Michigan General Electric, Philips Medical Systems

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Improvement in quality of MRI studies in Neuroradiology Specific Measurement Are:
Scan speed - is the new method as fast or faster than regular method(s)
Signal to noise - Subjectively, or quantitatively do we get the same, better, or new contrast compared to the regular methods(s).
Image contrast - Subjectively, or quantitatively do we get the same or better resolution compared to the regular method(s).
Spatial resolution - Subjectively, or quantitatively do we get the same or better resolution compared to the regular method(s).
Artifact - Subjectively, or quantitatively do we get the better artifact reduction compared to the regular method(s).
Ergonomics - Is the new software easier to work or offer more information more cleanly than the regular software
Patient comfort - Subjectively, does the new software and/or hardware make the patient's MRI experience more comfortable.
1 year
See also
  Status Clinical Trial Phase
Completed NCT05086809 - Investigation of an Updated Bone-anchored Sound Processor N/A
Completed NCT05080777 - Pilot Pragmatic Clinical Trial to Embed Tele-Savvy Into Health Care Systems N/A
Recruiting NCT03222375 - SQUEDâ„¢ Series 28.1 Home-use and Treatment of Autowave Reverberator of Autism N/A
Completed NCT03295786 - Clinical Study to Test the Safety of CDNF by Brain Infusion in Patients With Parkinson's Disease Phase 1/Phase 2
Completed NCT01915368 - Determining Optimal Post-Stroke Exercise (DOSE) N/A
Completed NCT01922258 - Safety and Tolerability Study of Flexible Dosing of Brexpiprazole in the Treatment of Subjects With Agitation Associated With Dementia of the Alzheimer's Type Phase 3
Terminated NCT03270189 - Effect of the Visual Information Change in Functional Dystonia N/A
Active, not recruiting NCT03911388 - HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors Phase 1
Completed NCT02798406 - Combination Adenovirus + Pembrolizumab to Trigger Immune Virus Effects Phase 2
Suspended NCT04912115 - Randomized, Double-Blind, Active Placebo-Controlled Study of Ketamine to Treat Levodopa-Induced Dyskinesia Phase 2
Completed NCT03994822 - pRESET for Occlusive Stroke Treatment N/A
Completed NCT03336645 - Open-label Study of Midazolam Hydrochloride Oromucosal Solution (MHOS/SHP615) in Children With Status Epilepticus (Convulsive) in a Healthcare Setting in Japan Phase 3
Completed NCT04283253 - Predictors of Response in Chronic Stroke N/A
Not yet recruiting NCT06048523 - Prospective Cohort Study of Neurogenetic Diseases N/A
Completed NCT02684825 - Detection of Silent Atrial Fibrillation aFter Ischemic StrOke N/A
Active, not recruiting NCT02284126 - Topical Vancomycin for Neurosurgery Wound Prophylaxis Phase 3
Completed NCT05815836 - Precision Medicine in Stroke
Recruiting NCT03678194 - Treating Depression on a Day-to-day Basis: Development of a Tool for Physicians Based on a Smartphone Application N/A
Recruiting NCT04698421 - Collection of Biological Samples From Patients With Rare Neurological Diseases
Recruiting NCT06111898 - Neuro-biomechanical Determinants for Motor Behavior in High-risk Infants